Michael Ackermann - Insider Trading & Ownership

Entity
Individual
Location
202 Carnegie Center, Suite 109, Princeton, New Jersey
Summary
The estimated net worth of Michael Ackermann is at least $273K dollars as of July 1, 2022. Michael Ackermann is the Director of Tarsus Pharmaceuticals, Inc. and owns shares of Tarsus Pharmaceuticals, Inc. (TARS) stock worth about $273K.
All Insider Reports
All Insider Reports

Ownership of Michael Ackermann

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TARS Tarsus Pharmaceuticals, Inc. Director $273K Jun 16, 2022

Insider Transactions Reported by Michael Ackermann:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.